- Investing | January 11, 2013
3 Things to Watch With Genomic Health
3 things to watch with Genomic Health.
- Investing | January 07, 2013
Illumina Wins One and Loses One
Illumina wins one deal but loses out on another.
- Investing | December 14, 2012
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Counting down the 12 days of Christmas in truly Foolish fashion!
- Investing | December 10, 2012
Amgen's $415 Million Bet on the Vikings
Why Amgen bet $415 million on the Vikings.
- Investing | December 06, 2012
The Worst of 2012: Pacific Biosciences of California
Continuing our countdown of the very worst healthcare stocks of 2012, at No. 16, Pacific Biosciences of California.
- Investing | November 22, 2012
OB/GYNs Give a Thumbs-Up to Sequenom
ACOG's recommendation of the company's prenatal test sends shares soaring.
- Investing | November 13, 2012
This Just In: More Upgrades and Downgrades
Is the Street starting to see things Sequenom's way?
- Investing | November 09, 2012
3 Biotechs Rocking Friday's Market
A quick look at some notable health care movers.
- Investing | November 02, 2012
Has Illumina Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
- Investing | November 01, 2012
What is the Meaning of Life Technologies?
The Fool philosophizes about the meaning behind Life Technologies' Q3 results.